Seamless Therapeutics

📍 Dresden, Germany🗓 Founded 2022👥 16 employees💰 Last funded Oct 2022
Biotechnology🌐 seamlesstx.com
Website LinkedIn
Seamless Therapeutics is changing the paradigm of gene editing through a pioneering approach to restore health in patients with severe conditions in a safe and precise manner. Our technology platform unlocks the reprogramming of recombinases, a highly versatile class of enzymes. We are applying our proprietary know-how to develop a pipeline of disease-modifying product candidates across a broad spectrum of indications to expand the therapeutic potential of gene editing.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2022
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Germany
1
Frequently asked questions
Who invested in Seamless Therapeutics?
Seamless Therapeutics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Seamless Therapeutics last raise funding?
The most recent investment in Seamless Therapeutics recorded on gritt.io was in October 2022.
When was Seamless Therapeutics founded?
Seamless Therapeutics was founded in 2022.
What industry is Seamless Therapeutics in?
Seamless Therapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Seamless Therapeutics based?
Seamless Therapeutics is headquartered in Dresden, Germany.